Scientific Conferences > Other Conferences
M.I.S. In The Management of Colon & Rectal Cancer - April, 18, 2012
To advance education and awareness of Minimally Invasive Surgery (MIS) within the Canadian surgical community and the public, the CCAC will be hosting an Advisory Council Meeting on April 18, 2012 in Toronto.
A key objective of the meeting is to generate a consensus statement focusing on the various aspects of MIS in the surgical management of colorectal cancer.
The 4th Québec Conference to Defeat Cancer "People First, Numbers Second!" - March, 29-30, 2012
The Coalition Priorité Cancer au Québec is hosting its 4th Quebec Conference to Defeat Cancer, scheduled to take place on March 29-30, at the Montreal Bonaventure Hilton.
Under the theme Cancer: a human challenge, first and foremost, the Coalition’s goal this year is to focus on patients, survivors and caregivers in an effort to understand and look beyond the statistics. Relying on vibrant testimonials that reflect the reality of those who are touched by cancer, and through captivating scientific conferences, the Coalition will discuss new issues in the battle against cancer, as well as existing problems in Quebec, with a view to offering practical solutions. For more information visit our Upcoming Events Section on our Website.
HIPEC Meeting -October 14, 2011
Newly formed by the CCAC, the Canadian HIPEC Collaborative Group (CHiCG) held a meeting in Montreal on October 14, 2011 to discuss Hyperthermic Intraperitoneal Chemotherapy (HIPEC), a surgical procedure involving the removal of metastatic disease to the abdominal lining (peritoneum) followed by infusion of heated chemo to the organs in the abdominal cavity. Some of Canada’s most influential oncology surgeons in this field worked tirelessly to produce a consensus document soon to be published in a prominent medical journal to be used for HIPEC awareness, education and advocacy. The CHiCG is committed to expanding their HIPEC efforts so colorectal cancer patients diagnosed with peritoneal mets are provided the best care possible.
Pan-Canadian Ostomy Supplies Reimbursement Policy Reform Meeting - March 2nd, 2012
On March 2nd, 2012, the CCAC hosted the Pan-Canadian Ostomy Supplies Reimbursement Policy Reform Meeting in Montreal. Issues such as the psychosocial impact of living with an ostomy, the psychosocial link between improved Quality of Life and optimal reimbursement of ostomy supplies, the health care costs associated with ostomy-related complications resulting from suboptimal reimbursement of ostomy supplies, and the complex health care system within which the current reimbursement policies are embedded were explored. The meeting was a glowing success as the group reached consensus on all proposed statements, to be published in early Fall.
Hereditary Colorectal Cancer Registry Meeting - Oct. 28, 2011
The CCAC held an important conference on the establishment of Hereditary Colorectal Cancer Registries throughout Canada, which will help to provide critical information and support to people affected by hereditary colorectal cancer, their family members who may be at risk, and the physicians overseeing the management of their care. Through a multidisciplinary approach, the brightest scientific experts across the country had an opportunity to come together to dialogue about the issues surrounding the management of hereditary syndromes. The outcomes of the meeting will be published and utilized for awareness, education and advocacy, as well as help pave the way to the timely establishment of Registries nationwide.
HAI in the Management of Unresectable Colorectal Liver Metastases Meeting - September 7th, 2012, Toronto
To advance education and awareness of Hepatic Arterial Infusion (HAI) as a therapeutic option in the treatment of unresectable colorectal liver metastases, the CCAC will be hosting an Advisory Council Meeting on September 7th, 2012 in Toronto at the Marriott Hotel Eaton Centre.
Liver metastases are a frequent complication of colorectal cancer, affecting over half of all colorectal cancer patients. Hence, the control and treatment of liver metastases is an important issue for both clinicians and patients.
In patients with liver-confined, but unresectable, metastatic disease, maximizing response rate in an effort to render these patients resectable is a goal shared by both patients and their treating oncologists. The Meeting will focus on the introduction of HAI in Canada as an additional option in the treatment of this select patient population.
A key objective of the Meeting is to generate a consensus document focusing on the various aspects of HAI in the management of colorectal liver metastases. This document will ultimately be submitted for publication in a prominent Journal and utilized for the promotion of HAI in appropriate circumstances. Our Meeting Chairs, Drs. Paul Karanicolas (HPB Surgical Oncologist) and Yooj Ko (Medical Oncologist), have been working diligently to create a comprehensive meeting agenda for this academically-driven initiative.
Health professionals, including hepatobiliary surgical oncologists and medical oncologists from across Canada and the U.S., will come together to identify barriers, document and advance solutions with the aim of promoting the use of HAI in Canada to improve the experience and outcomes of the colorectal cancer patient with confined, unresectable metastatic disease to the liver.